Prior to transplantation, IL-25, which depends on Lypd8 (an antibacterial molecule produced by intestinal cells in the colon that can inhibit the activity of flagella bacteria), can reduce IFN-γ and IL-6 in the plasma, protect goblet cells from GVHD, and prevent bacterial migration. Here, LYPD8 is linked to graft versus host disease.